Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events rsv risk healthy preterm babies how well do we understand it
… of therapies that address high unmet medical needs as well as the use of comparative clinical trials, and there are other factors as well. How is the pharmaceutical industry responding to these new … Act clock starts with the first approval. They might also do so because of the additional workload and the …
… of therapies that address high unmet medical needs as well as the use of comparative clinical trials, among other factors. How is the Pharmaceutical Industry Responding to These New … IRA clock starts with the first approval. They might also do so because of the additional workload and the …
… chart reviews also use real world data to help you better understand drivers that could influence your product … or budget impact models) Through our network of partners, we have access to patient charts in both developed and … From physician registries in each country of interest, we select participants based on specific characteristics …
… Adverse Cardiac Events in COPD Patients Treated with Inhaled Bronchodilators … a postauthorization safety study sponsored by AstraZeneca, we evaluated cardiovascular safety endpoints related to the use of aclidinium. The study evaluated the risk of acute myocardial infarction, stroke, and other major …
… it Matters: Understanding what competing drugs exist and how they are being prescribed helps position your technology … 4. Assess Early Pricing Potential Why it Matters: A well-defined pricing strategy can significantly impact your … favorable out-licensing terms by reducing perceived risk and highlighting market potential. Real-World Insight: …
The power of knowledge. The value of understanding. Generating knowledge and providing greater understanding so that life science and healthcare stakeholders—developers, regulators, payers, providers, and patients—can make better …
… you need substantiated, authoritative evidence and advice. We are scientists first—academically trained, credentialed researchers who know how and when to apply the appropriate research methodologies … Integrated Approach: The evidence you need, when you need it …
… Services (CMS) will most likely require, and learn how that evidence will be prioritized. The goal of the US … to QALYs include equal value of life-years gained (evLYG), Healthy Years in Total (HYT), and the Generalized Risk-Adjusted Cost-Effectiveness (GRACE) approach. However, …
… give feedback and provide comments to ensure that well-thought-through projects and initiatives will be … by the quality of our questions and comments, but also how cohesive as a team we came across and presented … thoughts on this, I’m always a bit concerned when agencies do not get back at all. Frank Distler Senior Director, …
… voice in drug development and has issued new guidelines on how to do so. At the same time, the health care industry has … been incorporated into research over the last 10 years, we studied industry-sponsored oncology clinical trials from …